There is currently no known treatment for Covid-19. So far, over 30,000 people are taking part in a range of NIHR supported COVID-19 research studies across the UK.
The Recovery RS study is comparing three NHS treatments to find out which is best at keeping oxygen levels high enough and preventing a patient from needing more help with their breathing
Dr James Dodd talks about the Discover study at North Bristol NHS Trust.
Hello my name is James Dodd, I'm a Consultant Respiratory Physician here at Southmead Hospital in Bristol and I'm the Principal Investigator for the Recovery Respiratory Support study. This is a national clinical trial that's been identified by the government as being of urgent public health priority. It's designed to be undertaken in adults admitted to hospital with confirmed or suspected Covid-19. And it's designed to determine what might be the best strategy of improving oxygen levels and helping to prevent patients from deteriorating and requiring more support with their breathing. It can put it compares three treatments that are already available in the NHS, one is CPAP, or continuous positive airway pressure, whereby an awake patient will have a tight-fitting mask fitted where continuous pressure is applied and delivers oxygen to keep the airways open and clear. The second is high flow nasal oxygen whereby humidified are moistened oxygen is delivered at speed through tubes up the nose to improve oxygen levels. And finally is to compare the standard treatment of oxygen masks or tubes up the nose. Nobody's currently clear as to which of these strategies is more effective. This study is designed to answer that question and the data will be reviewed regularly to identify if there is any treatment there is more effective and can be made available at speed to patients across the NHS. We have a dedicated team working seven days a week at Southmead Hospital made up of nurses, physiotherapists and doctors working the emergency respectable care areas to recruit to this important study.